Glucose tolerance in patients with narcolepsy

Sleep

Volumn 35, Issue 2, 2012, Pages 231-236

  Beitinger, Pierre A ^a   Fulda, Stephany ^a   Dalal, Mira A ^a   Wehrle, Renate ^a   Keckeis, Marietta ^a   Wetter, Thomas C ^a,b   Han, Fang ^d   Pollmac̈her, Thomas ^a,c   Schuld, Andreas ^c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c KLINIKUM INGOLSTADT   (Germany)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Hypersomnia; Hypocretin; Metabolism; Narcolepsy; Orexin

Indexed keywords

BEZAFIBRATE; CLOMIPRAMINE; FLUOXETINE; GLUCOSE; IODIDE; LAMOTRIGINE; LIOTRIX; MODAFINIL; PANTOPRAZOLE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NARCOLEPSY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE OXIDASE; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNOASSAY; INSULIN; INSULIN RESISTANCE; MALE; NARCOLEPSY;

EID: 84857004469     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.1628     Document Type: Article

References (30)

1. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40. (Pubitemid 30072183)
2. Dalal MA, Schuld A, Haack M, et al. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 2001;56:1749-51. (Pubitemid 32574579)
3. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
4. Lin L, Hungs M, Mignot E. Narcolepsy and the HLA region. J Neuroimmunol 2001;117:9-20. (Pubitemid 32595489)
5. Tsujino N. and Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76.
6. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-54. (Pubitemid 32530580)
7. Schuld A, Hebebrand J, Geller F, Pollmächer T. Increased body-mass index in patients with narcolepsy. Lancet 2000;355:1274-5. (Pubitemid 30184546)
8. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. (Pubitemid 47548277)
9. Honda Y, Doi Y, Ninomiya R, Ninomiya C. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 1986;9:254-9. (Pubitemid 18008505)
10. Roberts HJ. The syndrome of narcolepsy and diabetogenic ("functional") hyperinsulinism, with special reference to obesity, diabetes, idiopathic edema, cerebral dysrhythmias and multiple sclerosis (200 patients). J Am Geriatr Soc 1964;12:926-76.
11. Roberts HJ. The syndrome of narcolepsy and diabetogenic hyperinsulinism in the American Negro: important clinical, social and public health aspects. J Am Geriatr Soc 1965;13:852-85.
12. Poli F, Plazzi G, Di Dalmazi, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;29:1491-7.
13. American Sleep Disorders Association. ICSD International classification of sleep disorders: diagnostic and coding manual. Revised version. Lawrence, KS: Allen Press, 1997.
14. American Academy of Sleep Medicine. The international classification of sleep disorders: 2nd ed., diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
15. Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr 1986;43:167-72. (Pubitemid 16099799)
16. Diabetes Trials Unit, University of Oxford. HOMA2 Calculator v2.2. A software implementation of the HOMA2 model. Available from: http://www.dtu.ox. ac.uk/homa.
17. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70. (Pubitemid 29418240)
18. Morris SB, DeShon RP. Combining effect size estimates in metaanalysis with repeated measures and independent-groups designs. Psychol Methods 2002;7:105-25.
19. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria 2008. ISBN 3-900051-07-0. URL http://www.R-project.org.
20. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, WHO Press, 2006.
21. Burdakov D, Luckman SM, Verkhratsky A. Glucose-sensing neurons of the hypothalamus. Philos Trans R Soc Lond B Biol Sci 2005;360:2227-35. (Pubitemid 46682141)
22. Yamanaka A, Beuckmann CT, Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003;38:701-13. (Pubitemid 36694778)
23. Burdakov D. K+ channels stimulated by glucose: a new energy-sensing pathway. Pflugers Arch 2007;454:19-27.
24. Williams RH, Alexopoulos H, Jensen LT, Fugger L, Burdakov D. Adaptive sugar sensors in hypothalamic feeding circuits. PNAS 2008;105:11975-80.
25. Tsuneki H, Murata S, Anzawa Y, et al. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia 2008;51:657-67.
26. Delay J. Narcolepsie et hypoglycemie. Ann Med Psychol (Paris) 1942;100:375-9.
27. Lederer J. Narcolepsie par une hypoglycémie due à la leucine. Diabete 1962;10:254-7.
28. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-66. (Pubitemid 36163996)
29. Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000;61 Suppl 11:37-41. (Pubitemid 30616693)
30. Ferguson JM. SSRI Antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001;3:22-7. (Pubitemid 33807486)